#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Haemophilia B without inhibitors Ductal adenocarcinoma of pancreas Intracranial germ cell tumour Thrombotic thrombocytopenic purpura Skin angiosarcoma Antithrombin III deficiency Precursor T-lymphoblastic lymphoma/leukaemia recurrent Intracranial calcification Bulbospinal muscular atrophy congenital Marginal zone lymphoma Atopic keratoconjunctivitis Infertility male Autoimmune disorder Bronchiectasis Propionic acidaemia More trials…

    Learn about Rare Diseases

    Pemphigoid – Diagnostics Mucous membrane pemphigoid Langerhans’ cell histiocytosis Synovial sarcoma recurrent – Diagnostics Progressive multifocal leukoencephalopathy – Trials in Disease Rosai-Dorfman syndrome – Life with Disease Glomerulonephritis rapidly progressive – Treatment Krabbe’s disease – Trials in Disease Hyperoxaluria – Trials in Disease Angiosarcoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mk-2060 Tiratricol Tumor Necrosis Factor-Alpha S230815-2 Brepocitinib Tosilate ZOREVUNERSEN SODIUM Clarithromycin Paraffin White Soft Ucart22 Erythromycin A24110He Zofenopril Calcium Azd8630 CAMOSTAT MESILATE Emavusertib 12 Grass Pollen Mixture USNOFLAST Dexamethasone Phosphate Hydrocortisone Hemisuccinate Disodium Folinate More therapies…

    Learn about Your Condition

    Neuralgia Monkeypox Chordoma Sciatica Medication overuse headache Obstructive pancreatitis Metastatic gastric cancer Childhood asthma Proteus syndrome Endocarditis bacterial Cardiogenic shock Follicular thyroid cancer Intermittent claudication Psychological trauma Desmoid tumour More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study Comparing Meropenem and Piperacillin/Tazobactam for Adults with Sepsis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Sepsis
    • Septic shock
    Investigated Drugs:
    • Linezolid
    • Piperacillin Sodium
    • Tazobactam Sodium
    Denmark Sweden

  • Continued Access Study for Patients with Severe Hemophilia A Using Efanesoctocog Alfa

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Efanesoctocog Alfa
    Bulgaria France Germany Greece Italy The Netherlands +4

  • Study on the Effectiveness and Safety of Clindamycin and Tretinoin Gel for Patients with Papulopustular Acne

    Recruiting

    3 1 1
    Investigated Diseases:
    • Acne
    Investigated Drugs:
    • Tretinoin
    • Clindamycin
    Germany

  • Study Comparing Ustekinumab, Infliximab, and Combination Therapy for Patients with Moderate to Severe Ulcerative Colitis

    Recruiting

    2 1 1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Infliximab
    • Ustekinumab
    Poland

  • Study on 68Ga-FAPI-46 for Predicting Treatment Response in Early-Stage High-Risk Triple-Negative Breast Cancer Patients Undergoing Chemo-Immunotherapy

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Epirubicin Hydrochloride
    • (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
    • Doxorubicin Hydrochloride
    France

  • Study Comparing Rivaroxaban and Drug Combination for Preventing Blood Clots in Patients with Lower Limb Injuries Requiring Immobilization

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Joint stabilisation
    Investigated Drugs:
    • Tinzaparin Sodium
    • Dalteparin Sodium
    • Enoxaparin Sodium
    France
Previous Page
1 … 466 467 468 469 470 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!